ReviewFrontiers in oncology2022

SIRT1, a novel transcriptional downstream target of CD44, linking its deacetylase activity to tumor cell invasion/metastasis.

Salma M S Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.